Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Retained Earnings: 2018-2024

Historic Retained Earnings for Bicycle Therapeutics (BCYC) over the last 7 years, with Dec 2024 value amounting to -$680.8 million.

  • Bicycle Therapeutics' Retained Earnings fell 39.86% to -$879.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$879.6 million, marking a year-over-year decrease of 39.86%. This contributed to the annual value of -$680.8 million for FY2024, which is 33.03% down from last year.
  • As of FY2024, Bicycle Therapeutics' Retained Earnings stood at -$680.8 million, which was down 33.03% from -$511.8 million recorded in FY2023.
  • Over the past 5 years, Bicycle Therapeutics' Retained Earnings peaked at -$151.6 million during FY2020, and registered a low of -$680.8 million during FY2024.
  • Moreover, its 3-year median value for Retained Earnings was -$511.8 million (2023), whereas its average is -$507.9 million.
  • Data for Bicycle Therapeutics' Retained Earnings shows a maximum YoY plummeted of 54.57% (in 2023) over the last 5 years.
  • Yearly analysis of 5 years shows Bicycle Therapeutics' Retained Earnings stood at -$151.6 million in 2020, then plummeted by 44.09% to -$218.4 million in 2021, then crashed by 51.62% to -$331.1 million in 2022, then slumped by 54.57% to -$511.8 million in 2023, then tumbled by 33.03% to -$680.8 million in 2024.